Riboxin Inosine injection 20mg/ml 5ml/10 amp

Riboxin Inosine injection Composition:

active ingredient: inosine; 1 ml of solution contains riboxin (inosine) 20 mg;

excipients: sodium hydroxide, water for injection.

Indications

-Cardiac ischemia

– Cardiac arrhythmias, including cardiac glycosides obuslovlennyeprimeneniem

– Cardiomyopathy of various origins

– Congenital and acquired heart defects

– Myocarditis

– Coronary atherosclerosis

– “Pulmonary” heart

– Degenerative changes of the myocardium after severe physical work and infectious diseases

– Liver cirrhosis, acute and chronic hepatitis, alcoholic midicamental liver damage, fatty liver

– Operation on the isolated kidney.

Dosage & Administration

Riboxinum-Darnitsa (intraveneous injection solution 2%) .

Intravenously administered slowly (40-60 drops to 1 minute) infusion or bolus. First administered 200 mg (10 ml of a 2% solution) 1 time per day in terms vposleduyuschie good tolerability – 400 mg (20 ml of a 2% solution) 1-2 times a day. The course of treatment – 10-15 days.

Stream introduction of possible acute disorders ritmaserdtsa a single dose of 200-400 mg (10-20 ml of 2% solution).

For pharmacological protection kidneys undergoing ischemia is administered intravenously in razovoydoze 1.2 g (60 ml of a 2% solution) for 5-15 minutes before the renal artery clamping, AZAT another 0.8 g (40 ml of a 2% solution) immediately after restore circulation.

With a drip into a vein 2% solution of the drug razvodyatv 5% glucose solution or isotonic sodium chloride solution (250 ml).

Side effects

– Allergic reactions: itching, skin hyperemia

– Increase in the concentration of uric acid in the blood

– Exacerbation of gout chronic administration of high doses.

Contraindications

– hypersensitivity to the drug

– gout

– hyperuricemia

– pregnancy and lactation

– children up to age 18 years.